researchers from genentech are going to be focusing on 300 members of an extended family in columbia.they all share a mutation that can trigger alzheimer's as early as their mid-40s. scientists hope to learn if an experimental drug can hold off the on set of the disease. >>> the a's are in progress and it doesn't look like it's going too well. >> they better get the on the ball in a hurry. for the a's i bet they wish it would start later because it didn't go well from the beginning but i tell you ever single game it seems like. highlights josh redick this time on defense. nice play, alberto callespo you are out. beautiful throw. the guy has a sensational arm. but the next time callespo comes to the plate. redick is not going to get him. he shoots it down the right field line, got himself an rbi double in the person of mike trous. the angels so far with the only run they need but they've got albert pujols in their line up. this guy has been in such a slump but he gets a break today. in fact, a couple of them off the glove of bartolo colon. pujols has three hits in the game all of them

most companies, like i mentioned when aol went public, used to apple and genentech and intel, hewlett-packard, a whole generation of companies that led the '70s and '80s and '90s when they were relatively young in their life cycle, used a public offering as a way to access the capital necessary to drive their expansion and growth, which fueled the creation of in some cases hundreds of thousands of jobs. that's the way it was. 20 years ago, 80% of the public offerings were under $50 million. lately it's been under 20% under $50 million. it's trying to create an on-ramp for these younger capitals to access capital for a limited period of time, until five years, that they're able to go back to the markets that we had that were robust 10, 20 years ago. there were some abuses. when people make investments, whether it be an ipo or investment company, some of those companies will fail. that's the nature of capitalism and risk. the key is have we struck the right balance in terms of protecting the downside, in terms of responsible rules around funding platforms, how they're regulated, and making sure

. >>> genentech awaiting approval.ncisco based company should hear by june 8th if the fda has okayed pertuzimab. it expects to file for approval of a fourth cancer drug that is less toxic before the end of the year. >>> when it comes to basketball star jeremy lin what is in a name? >> plus excitement in space. the history making rendezvous that has been happening. it will happen very soon at the international space station. ♪ then we turned the page, creating the rx hybrid. ♪ now we've turned the page again with the all-new rx f sport. ♪ this is the next chapter for the rx. this is the next chapter for lexus. this is the pursuit of perfection. distinct conversation ]er for lexus. did somebody just...? impossible. ♪ yes. yes. yes. noooooooo! [ male announcer ] yep, subway broke the 200-calorie breakfast barrier with delicious subway fresh fit breakfast sandwiches. like the black forest ham, egg white & cheese on mornin' melt flatbread. subway. build your better breakfast. with the touch of a button ? droid does. does it

and since we have gone on to receive backing from harvard medical school and the mayo clinic and genentechnd players that are interested. >> we just had the doctor on from md cancer center and talk about innovation there as well. you have seen money move into health care and technology or what? is this where you are seeing money as well as big packers? >> absolutely. the u.s. health care system accounts for nearly 20% of gdp. it's hard to break into. it's hard to move into health care. >>> you the next mark zuckerberg. >> no, but the next mark zuckerberg will come through rock health absolutely. >> congrts and we will see you soon. >> thank you very much. >> it's time to reveal the winner of the call the close contest. drumroll, please. and the winner is, mark chung from new york city meat the closest call, two cents off of facebook's close at 38.23. thank you to everybody who participated. thank you very much for that. sticker shock at the podium. college graduates face student debt and my observation on the cost of higher education next. paying tribute to a punk robt tribute what would h

how do you think genentech has made it? they perform outside the box.ind an antibiotic. it was a sloppy scientist with a mold in a part of his lab. and guess what? nothing was growing around it. eureka, a moment. there are crazy young people with wild ideas. we should fund them. but increasingly those crazy ideas are happening in countries outside of the united states. and that's what worries me. we have to really challenge ourselves to think outside the box. what's the worst thing that could happen? some people fail. you waste a couple of million dollars. for a far ma company, it's a rounding error. i was on the lines when hiv/aids came through san francisco. you could literally kill me. so i gowned and gloved and put on a mask and i separated myself from you. what i'm urging young doctors to do now is take off those gloves and touch people. the physician is a healer first and foremost. and human touch can heal. the technology helps that. but when the technology gets in the way or the fear of the patient gets in the way, you can't help somebody. >> you

i cannot believe -- >> why did you lose -- >> i genentech to say, the thing is this just confirms toe that the big institutions, the big hedge funds who sold on that opening print had a good feel. >> amazing. if you're retail and felt you were missing out on it you clearly were not because you can buy facebook at 12 cents above the offering price. i should point out one of the largest ipos we've seen prior to facebook and one high-profile but a different profile fundamentally with gm. gm priced at $33 a share. people may recall first day trade up 3 poif 6%, closed at 34.19. the same under writers. same under writers as facebook on the gm ipo. so they did a nice job there but okay, we're about to break syndicate -- >> you see what happens. >> not a good sign for the market. >> they had those orders in there. >> once those orders were filled you immediately then started to get what were sort of market orders that came in and did not get the follow through. >> we haven't broke syndicate bid. they might want to hold that wall. >> those huge number of banks. >> $38. >> 38 unchanged. we ju